Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790070 · ClinicalTrials.gov registry record · NA
Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle
A NA study of Blood Flow Restriction Training and Betaine Supplementation, sponsored by Baylor University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05790070 is a NA study of Blood Flow Restriction Training and Betaine Supplementation that has completed, run by Baylor University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05790070, a NA study of Blood Flow Restriction Training and Betaine Supplementation, has completed, sponsored by Baylor University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether there is a synergistic effect via combining both low-load blood flow restriction (BFR) training and betaine supplementation loading (6g/day for 14 days) on skeletal muscle anabolic signaling pathways that is mediated by enhancements in intracellular water. These effects are proposed to be greater than either BFR training or betaine supplementation alone or compared to control conditions (high-load non-occluded and/or placebo supplementation).
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Betaine
Study Locations (1)
Texas
- Baylor University - Waco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05790070
The ClinicalTrials.gov registry entry for NCT05790070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor University, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Blood Flow Restriction Training appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05790070 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05790070 about?
NCT05790070 is a clinical study titled "Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle". The purpose of the study is to determine whether there is a synergistic effect via combining both low-load blood flow restriction (BFR) training and betaine supplementation loading (6g/day for 14 days) on skeletal muscle anabolic signaling pathways that is mediated by enhancements in intracellular w...
What is the current status of trial NCT05790070?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-02-01. Estimated completion is 2021-07-30.
What conditions does trial NCT05790070 study?
This clinical trial studies the following conditions: Blood Flow Restriction Training, Betaine Supplementation.
What interventions are being tested in trial NCT05790070?
The interventions under investigation include: Placebo (OTHER), Betaine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05790070?
This trial is sponsored by Baylor University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05790070 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.